Hepatic venous pressure gradient measurement guiding nonselective beta‐blocker therapy in a patient with clinically significant portal hypertension

Clinically significant portal hypertension (CSPH), defined as a hepatic venous pressure gradient (HVPG) ≥ 10 mmHg, is an independent risk factor for decompensated events in patients with compensated cirrhosis. Currently, the Baveno VII consensus recommends using nonselective beta‐blockers to treat c...

Full description

Saved in:

Bibliographic Details
Published in:	Portal hypertension & cirrhosis (Print) Vol. 2; no. 2; pp. 105 - 108
Main Authors:	Wang, Kun, Tian, Minghui, Zhang, Linpeng, Liu, Shanghao, Guo, Xiaoqing, Ma, Jianzhong
Format:	Journal Article
Language:	English
Published:	Nanjing John Wiley & Sons, Inc 01.06.2023 Wiley
Subjects:	Abdomen Antigens Blood pressure Case reports Catheters Clinical significance Drug dosages Heart rate Hepatic venous pressure gradient Hepatitis B Hypertension Liver cancer Liver cirrhosis Liver diseases Medical imaging Medical prognosis Non‐selective beta‐blocker Patients Pharmacists Portal hypertension Veins & arteries
ISSN:	2770-5846, 2770-5838, 2770-5846
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!